The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Some large buys from yesterday did not show up. Usually good sign.
Good luck all.
Added more this week, why?
1. 2006 – Share price was around 55p on average, long term holders likely averaging around 70p to 110p.
2. Jan 2018 – SP reached over 180p, however the SP reduced due to their drug not being any better than placebo (potentially due to such a small sample size).
3. November 2019 – SP reached over 28p (from its lows of 7p) – This was after Avion Pharmaceutical’s deal to fund a second phase 3 study. Avion Pharmaceutical invested $25m.
4. May 2020 –The potential of Lupuzor against Covid 19 - further positive news on this will see a huge rerate in the SP. Lupuzor considers T-Cells. There have already been many Pharma companies that have drugs which target the T-Cells and shown positive signs against Covid 19, i.e Heat Biologics and Tonix Pharmaceuticals (DYOR).
5. June 2020 – Look at the Proactive investor interview with Tim McCarthy (the chairman), you can see Tim’s face when discussing the second phase 3 trial. If there were any signs of a failed phase 3 or if something went wrong with the trial, the company will have to update the market immediately. This is a larger study and will hopefully show the drug has a better response compared to placebo.
Considering the current stage of the company, we believe it is severely undervalued. 50p or more is possible in the next 2 weeks. We believe a successful second Phase 3 could see the SP easily retrace back towards 180p, and even more. The company are a few years away from commercialising a product, Avion Pharmaceutical would not blindly invest $25m if they did not see the potential of the drug being successful in a larger placebo, nor discuss potential commercialisation figures. Also, Lanstead Capital Investor would not continue to invest into the company if they did not believe in it.
Good luck all and stay safe.
Do let me know if you get back in.
IG currently taking a while, hoping my order gets filled before 9am bounce.
Hope my order gets filled, before SP gets back to 13!
Must be lots of background trades occurring!
Good luck all. Remember the fundamentals.
1. To avoid takeover
2. 5G future play which is a Trillion dollar market, no doubt BT has the structure already in place to obtain a large portion of this market (In the Billions). Hence why private takeover are eyeing them up.
3. Severely undervalued even before takeover rumour.
DYOR, long term holders will be rewarded.
Good luck all.
AA PLC first had rumours of takeover at 40p, AA PLC hit this SP just over a week later. Should see the same with BT. Look at the massive buys going through.
What a steal.
Good luck all.
400p in the short term.
Read Asos market expectations for revenue and sales to get a guide on fast fashions online performance. Look at how their SP has been performing, Boohoo would have followed suit if there was no issue of Leicester scandal which has already been rectified.
Asos: “ Today we are announcing that sales and profit for the full year are expected to be significantly ahead of market expectations.“
You won’t see a bargain like this for some time. Major rerate due.
Good luck all
Exactly. Based on just the placing itself - that should be only a 7% dilution. Not this over reaction. Time to buy.
Will see £45m in the near future.
Good luck all holders
Marketcap will be at least £45m in the short term.
Adding.
Good luck all
Good luck all
Confident we'll be over 20p very soon. Last year we managed to without any of the current fundamentals at hand.
Good luck all.
Good news ahead.
Good luck all.
Very likely.
Good luck everyone
When news on the Russia approval is made, we should see easily well above 20p
Good luck all holders.
Believe there will be good news soon with Evotec's partnerships and good updates, could see this back to 13p instantly, and then towards 2018 highs of over 30p.
Hope the long term holders are also rewarded.
Good luck all.
A large order of 2.27 was just paid. Did not go through. Strange.
Depending on buying pressure.
On news this will reach all time highs. Predict news will be this week. Hopefully we’re right.
Good luck all!
Seems to be going in the right direction, hopefully they are not too late to the Party. All the best to long term holders.
GLA
Would not be surprised to see an RNS soon stating a clinical trial for NXP002 to be used for COVID 19, or even a pre-clincal study with NXP004 . Some decent buys went through before close, something seems around the corner.
Good luck holders.
Good company. Recommended this to investors, however, only concern is extension of the lock down. Could see this drift further if that's the case.